Skyline Medical Inc. is exploring a merger with privately held CytoBioscience Inc., a Texas-based healthcare manufacturer and contract research organization.

The companies have entered a so-called letter of intent to explore a merger. Assuming the parties enter a definitive agreement, the transaction would close by Sept. 30.

CytoBioscience has reported a current backlog of $6 million in orders and anticipated contract research work.